TC
EBS icon

Truvestments Capital’s Emergent Biosolutions EBS Stock Holding History

Truvestments Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.53K Buy
+421
New +$3.52K ﹤0.01% 954

Other funds holding EBS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Truvestments Capital's EBS Position: Q2 2026 in Review

Truvestments Capital opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 421 shares worth $3.53K. The stake represents ﹤0.01% of the portfolio and ranks #954 among its holdings.

195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • Truvestments Capital held 421 shares of Emergent Biosolutions worth $3.53K as of Q2 2026.
  • Emergent Biosolutions was a new Truvestments Capital position in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #954 holding.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.